Spectrum Chemicals & Laboratory Products announces a new chemicals distribution agreement with TCI America making Spectrum the primary US distributor of over 22,000 unique chemicals for research and science.
Spectrum Chemicals & Laboratory Products announces a new consumables distribution agreement with PerkinElmer, Inc. and the release of a 2012 | 2013 Chromatography & Spectroscopy Products Catalog.
Thermal hazards and Calorimetry is a major field of expertise within HEL and this has grown to such an extent that we have launched a dedicated website. This is the first website of its kind in encompassing a wide range of thermal hazard and calorimetry products.
Spectrum Chemical Mfg. Corp announced a new expanded line of over 50 kosher certified chemicals
Intelsius, a DGP company, a designer, manufacturer and distributor of temperature-controlled packaging solutions, announces the launch of its new ORCA™ range of products.
The British and Norwegian governments are to work together to support nine new research
and development projects that will create innovative processes to generate high-‐value chemicals through industrial biotechnology and bio-‐refining.
Meet Biovian at the Biotech Outsourcing Strategies cmc2012 (BOS cmc) on 14 June 2012 at the Sohuset Conference Center, Denmark. Biovian's director of business development and projects, Dr Knut Ringbom, will be available for in-depth disussions with delegates at the conference.
Meet Biovian at 'Lyckad Läkemedelsutveckling' seminar on 31 May 2012 at Hotel Grand, Stockholm, Sweden. Biovian's Director of Business Development and Projects, Dr Knut Ringbom will be available for in-depth disussions with delegates at Biovian's stand.
Sera Laboratories International Ltd (Sera Lab), the serum specialist, has introduced the novel SplitKits cell dissociation system, the first specifically designed for use in both serum-based and serum-free methodologies.
Aptalis Pharmatech, Inc. (previously known as Eurand, Inc.) and Cephalon, Inc. a wholly-owned subsidiary of Teva Pharmaceuticals Industries Ltd, and Anesta AG prevailed in their appeal to the U.S. Court of Appeals for the Federal Circuit which reversed a lower court’s determination and held that two patents covering the AMRIX® muscle relaxant (Cyclobenzaprine Hydrochloride Extended-Release Capsules) are valid.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.